Dysport [botulinum toxin A] injection in the treatment of chronic lateral epicondylitis

Trial Profile

Dysport [botulinum toxin A] injection in the treatment of chronic lateral epicondylitis

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Mar 2009

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Musculoskeletal pain; Tennis elbow
  • Focus Therapeutic Use
  • Acronyms DCLE
  • Most Recent Events

    • 22 Apr 2008 The actual completion date for this trial is now 1 Apr 2008.
    • 22 Apr 2008 Status changed from recruiting to completed.
    • 17 Sep 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top